Two-stepping through time: Mammals and viruses

Trends in Microbiology

Volumn 19, Issue 6, 2011, Pages 286-294

  Meyerson, Nicholas R ^a   Sawyer, Sara L ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MARAVIROC; VIRUS CAPSID ANTIGEN; VIRUS PROTEIN;

ADAPTIVE BEHAVIOR; ANTIGEN ANTIBODY COMPLEX; EVOLUTION; FOSSIL ANIMAL; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAMMAL; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; VIRUS CELL INTERACTION; VIRUS EXPRESSION; VIRUS GENOME;

ANIMALS; BIOLOGICAL EVOLUTION; HOST-PATHOGEN INTERACTIONS; MAMMALS; VIRUS PHYSIOLOGICAL PHENOMENA; VIRUSES;

ANIMALIA; MAMMALIA;

EID: 79957868276     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2011.03.006     Document Type: Review

References (76)

1. Haldane J.B.S. Disease and Evolution. La Ricercha Scientifica 1949, 19:68-76.
2. Johnson W.E. Endless forms most viral. PLoS Genet. 2010, 6:e1001210.
3. Lander E.S., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
4. Trowsdale J., Parham P. Defense strategies and immunity-related genes. Eur. J. Immunol. 2004, 34:7-17.
5. Emerman M., Malik H.S. Paleovirology - modern consequences of ancient viruses. PLoS Biol. 2010, 8:e1000301.
6. Dawkins R., Krebs J.R. Arms races between and within species. Proc. R. Soc. Lond. B 1979, 205:489-511.
7. Vogel T.U., et al. Major histocompatibility complex class I genes in primates: co-evolution with pathogens. Immunol. Rev. 1999, 167:327-337.
8. Bowie A.G., Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 2008, 8:911-922.
9. Parham P., et al. Primate-specific regulation of natural killer cells. J. Med. Primatol. 2010, 39:194-212.
10. Liu S., et al. New developments in the induction and antiviral effectors of type I interferon. Curr. Opin. Immunol. 2011, 23:57-64.
11. Worobey M., et al. Point, counterpoint: the evolution of pathogenic viruses and their human hosts. Annu. Rev. Ecol. Evol. Syst. 2007, 38:515-540.
12. Neil S., Bieniasz P. Human immunodeficiency virus, restriction factors, and interferon. J. Interf. Cytok. Res. 2009, 29:569-580.
13. Nisole S., et al. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 2005, 3:799-808.
14. Evans D.T., et al. BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol. 2010, 18:388-396.
15. Goila-Gaur R., Strebel K. HIV-1 Vif APOBEC, and intrinsic immunity. Retrovirology 2008, 5:51.
16. Emerman M. How TRIM5alpha defends against retroviral invasions. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:5249-5250.
17. Johnson W.E., Sawyer S.L. Molecular evolution of the antiretroviral TRIM5 gene. Immunogenetics 2009, 61:163-176.
18. Sawyer S.L., et al. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:2832-2837.
19. Gupta R.K., et al. Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog. 2009, 5:e1000443.
20. Lim E.S., et al. Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency virus and primate lentiviruses. J. Virol. 2010, 84:7124-7134.
21. McNatt M.W., et al. Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog. 2009, 5:e1000300.
22. O'Brien S.J., Moore J.P. The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol. Rev. 2000, 177:99-111.
23. Watanabe T., et al. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 2010, 7:427-439.
24. Bushman F.D., et al. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog. 2009, 5:e1000437.
25. Zhang Z.D., et al. Rapid evolution by positive Darwinian selection in T-cell antigen CD4 in primates. J. Mol. Evol. 2008, 66:446-456.
26. Demogines A., et al. Ancient and recent adaptive evolution of primate non-homologous end joining genes. PLoS Genet. 2010, 6:e1001169.
27. Kirmaier A., et al. TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS Biol. 2010, 8:e1000462.
28. Wain L.V., et al. Adaptation of HIV-1 to its human host. Mol. Biol. Evol. 2007, 24:1853-1860.
29. Naffakh N., et al. Host restriction of avian influenza viruses at the level of the ribonucleoproteins. Annu. Rev. Microbiol. 2008, 62:403-424.
30. Van Valen L. A new evolutionary law. Evol. Theor. 1973, 1:1-30.
31. Riddick N.E., et al. A novel CCR5 mutation common in sooty mangabeys reveals SIVsmm infection of CCR5-null natural hosts and efficient alternative coreceptor use in vivo. PLoS Pathog. 2010, 6:e1001064.
32. Chen Z.W., et al. Natural infection of a homozygous Delta 24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus. J. Exp. Med. 1998, 188:2057-2065.
33. Mosier D.E. How HIV changes its tropism: evolution and adaptation?. Curr. Opin. HIV AIDS 2009, 4:125-130.
34. Schliekelman P., et al. Natural selection and resistance to HIV. Nature 2001, 411:545-546.
35. O'Brien S.J., Nelson G.W. Human genes that limit AIDS. Nat. Genet. 2004, 36:565-574.
36. Woolhouse M.E.J., et al. Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat. Genet. 2002, 32:569-577.
37. Brass A.L., et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus West Nile virus, and dengue virus. Cell 2009, 139:1243-1254.
38. Sawyer S.L., et al. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2004, 2:e275.
39. Carrington M., et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999, 283:1748-1752.
40. O'Connor S.L., et al. MHC heterozygote advantage in simian immunodeficiency virus-infected Mauritian cynomolgus macaques. Sci. Transl. Med. 2010, 2:22ra18.
41. Newman R.M., et al. Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5 alpha. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:19134-19139.
42. Kosiol C., et al. Patterns of positive selection in six mammalian genomes. PLoS Genet. 2008, 4:e1000144.
43. Gibbs R.A., et al. Evolutionary and biomedical insights from the rhesus macaque genome. Science 2007, 316:222-234.
44. Mikkelsen T.S., et al. Initial sequence of the chimpanzee genome and comparison with the human genome. Nature 2005, 437:69-87.
45. Hughes A.L., Nei M. Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature 1988, 335:167-170.
46. Elde N.C., et al. Protein kinase R reveals an evolutionary model for defeating viral mimicry. Nature 2009, 457:485-489.
47. Li Y., et al. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection. J. Virol. 2006, 80:6738-6744.
48. Stremlau M., et al. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J. Virol. 2005, 79:3139-3145.
49. Yap M.W., et al. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction. Curr. Biol. 2005, 15:73-78.
50. Kaiser S.M., et al. Restriction of an extinct retrovirus by the human TRIM5alpha antiviral protein. Science 2007, 316:1756-1758.
51. Perron M.J., et al. Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5 alpha. J. Virol. 2006, 80:5631-5636.
52. Hatziioannou T., et al. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:10774-10779.
53. Yap M.W., et al. TRIM5alpha protein restricts both HIV-1 and murine leukemia virus. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:10786-10791.
54. Perron M.J., et al. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:11827-11832.
55. Keckesova Z., et al. The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:10780-10785.
56. Malim M.H. APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos. Trans. R. Soc. B 2009, 364:675-687.
57. Schrofelbauer B., et al. A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc. Natl. Acad. Sci. U.S.A. 2004, 101:3927-3932.
58. Bogerd H.P., et al. A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:3770-3774.
59. Xu H., et al. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:5652-5657.
60. Simon V., et al. Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification. PLoS Pathog. 2005, 1:20-28.
61. Sauter D., et al. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 2009, 6:409-421.
62. Palacios E., et al. Parallel evolution of CCR5-null phenotypes in humans and in a natural host of simian immunodeficiency virus. Curr. Biol. 1998, 8:943-946.
63. Wilson S.J., et al. Rhesus macaque TRIM5 alleles have divergent antiretroviral specificities. J. Virol. 2008, 82:7243-7247.
64. Song B., et al. The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates. J. Virol. 2005, 79:6111-6121.
65. Ohkura S., et al. All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction. J. Virol. 2006, 80:8554-8565.
66. Delport W., et al. Frequent toggling between alternative amino acids is driven by selection in HIV-1. PLoS Pathog. 2008, 4:e1000242.
67. Reszka N., et al. Simian TRIM5α proteins reduce replication of herpes simplex virus. Virology 2010, 398:243-250.
68. Kuo R.L., et al. Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-β transcription. Virology 2010, 408:146-158.
69. Huang I.C., et al. Distinct patterns of IFITM-mediated restriction of filoviruses SARS coronavirus, and influenza A virus. PLoS Pathog. 2011, 7:e1001258.
70. Lu J., et al. The IFITM Proteins Inhibit HIV-1 Infection. J. Virol. 2011, 85:2126-2137.
71. Kerns J.A., et al. Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein. PLoS Genet. 2008, 4:e21.
72. Ortiz M., et al. Evolutionary trajectories of primate genes involved in HIV pathogenesis. Mol. Biol. Evol. 2009, 26:2865-2875.
73. Bush R.M., et al. Predicting the evolution of human influenza A. Science 1999, 286:1921-1925.
74. Bloom J.D., et al. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 2010, 328:1272-1275.
75. Cao W., et al. Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J. Exp. Med. 2009, 206:1603-1614.
76. Tareen S.U., Emerman M. Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition. Virology 2011, 409:113-120.